| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.37 | 9e-30 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.35 | 7e-13 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-13 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-12 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.33 | 2e-11 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-10 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.28 | 6e-10 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.12 | 4e-06 |